Im sure its preliminary though. If my image loads.
Whats Next: phase 2 study of PdL1 Negative mTnbc patients:
Open Label/Randomized
Lead in w/ Lronlimab (525 vs 700mg) and 2 cycles of Chemo with ICI added Day 42.
https://www.vumedi.com/video/sabcs-2025-panel...-in-mtnbc/
Im thinking the EAP might be similar to this except with 700mg exclusively.
So 42 day timeline after Leron initiated.
An nearly march kickoff (for EAP) would be nice!
Tnbc fda approval too